The hon. Gentleman is talking of his concerns about such risks. In my constituency, I have a life sciences company called Hologic, which has just told me that it is on the verge of losing a major contract because of the threat in relation to reciprocal agreements and the regulatory framework for batch releases. It is very concerned about job losses and about losing contracts. Does he recognise that, for many companies in my constituency, such as Hologic, not knowing means that, in their words, the game is potentially a bogey?